Measured Wealth Private Client Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.9K Hold
490
0.01% 345
2026
Q1
$41.8K Hold
490
0.01% 318
2025
Q4
$38.7K Hold
490
0.01% 346
2025
Q3
$39.2K Buy
+490
New +$41.8K 0.01% 335
2021
Q1
Sell
-2,401
Closed -$205K 159
2020
Q4
$205K Buy
+2,401
New +$199K 0.09% 130
2018
Q4
Sell
-927
Closed -$62K 206
2018
Q3
$62K Buy
+927
New +$61.7K 0.04% 304

Other funds holding CL

Measured Wealth Private Client Group's CL Position: Q2 2026 in Review

Measured Wealth Private Client Group held its Colgate-Palmolive (CL) position steady in Q2 2026 at 490 shares worth $44.9K. The position accounts for 0.01% of the portfolio, ranked #345.

Measured Wealth Private Client Group first reported a position in CL in Q3 2018 and has held it in 6 quarters since. The position peaked at $205K in Q4 2020. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Measured Wealth Private Client Group held 490 shares of Colgate-Palmolive worth $44.9K as of Q2 2026.
  • Measured Wealth Private Client Group left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.01% of Measured Wealth Private Client Group's portfolio in Q2 2026, its #345 holding.
  • Measured Wealth Private Client Group first reported a position in Colgate-Palmolive in Q3 2018 and has held it in 6 quarters since.
  • Measured Wealth Private Client Group's Colgate-Palmolive position peaked at $205K in Q4 2020.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Measured Wealth Private Client Group's 13F filing for Q2 2026, filed 10 Aug 2026.